Hospice Insights Podcast - PPEO Playbook: The High-Stakes Game Hospices Can’t Afford to Lose
Podcast - Assessing the State of Healthcare Restructurings
Leaders in Law: Life Sciences and Technology Transactions with Jekkie Kim
Health-e Law Podcast, Episode 22 | J.P. Morgan Healthcare 2026 and Beyond: Regulation, Technology and the Future of Health Equity
Podcast — Spotlight on US State Healthcare Transaction Review Laws
Taking the Pulse: A Health Care and Life Sciences Video Podcast | Episode 268: Inside South Carolina’s Life Sciences Growth with James Chappell of SCbio
JONES DAY TALKS®: The CNPV Pilot Program: FDA's High-Speed Lane for Drug Approval
Hospice Insights Podcast - Endings and Beginnings: Reflections on Meg Pekarske’s 25+ Years as a Hospice Advocate
Health-e Law Podcast, Episode 21 | J.P. Morgan Healthcare 2026 and Beyond: Technology Adoption and Strategic Transformation Under Cost Pressure
Got an Audit Letter? Here’s What Every Health Care Provider Should Do
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 267: Leading Legal Strategy at a Growing Health System with Kelli Ferry of Novant Health
We get AI for work™: Preparing Real-World Healthcare Environments for an AI-Driven Future
Health-e Law Podcast, Episode 20 | J.P. Morgan Healthcare 2026 and Beyond: How Digital Innovation Shapes Healthcare M&A
Podcast - Minority Deals in Healthcare Private Equity: An Evolving Opportunity for GPs and Founders Counsel That Cares Podcast Series
Pay Transparency + the Power of Preventive Strategies: Episode 3 — Pivoting Toward Preparation in the Life Sciences
Pay Transparency + the Power of Preventive Strategies: Episode 2 — Healthcare Compliance Crossroads
Taking the Pulse, A Health Care and Life Sciences Video Podcast | Episode 266: Navigating Today’s Healthcare Landscape with Leighton Roper of Maynard Nexsen
Hospice Insights Podcast - Reimagining How We Navigate Change and Loss: A Conversation with Sonya Dolan and Bridget Sumser of Mettle Health
Podcast - The Fast-Growing Wound Care Industry
Concierge Practices: Getting Started and Staying Compliant
The FTC’s insulin/pharmacy benefit managers (PBM) enforcement matter is starting to look less like a single case—and more like a regulatory reset executed through settlement. On March 3, 2026, the FTC extended the stay...more
Most employers and their insurance resources are aware of the abusive cost structures associated with prescription compound topical drugs/creams being sold to our Commonwealth’s injured workers. The central objection about...more
On March 5, the Department of Justice announced that it secured a Deferred Prosecution Agreement (“DPA”) with ExThera Medical Corporation after a former executive admitted to concealing the death of patients who were treated...more
For years, U.S. cybersecurity policy has largely followed a familiar formula: strengthen defenses, share threat intelligence, and improve resilience after attacks occur. But as ransomware gangs cripple hospitals, nation-state...more
Maryland's health care noncompete and conflict of interest law, passed in 2024 but effective July 1, 2025, was intended to solve a host of problems with respect to noncompetition and similar agreements in Maryland's...more
Welcome to Venable’s BiologicsHQ Monthly Injection - February 2026....more
The Calendar Year 2026 Physician Fee Schedule Final Rule includes several targeted, but material, changes to the average sales price (ASP) calculation and reporting that directly impact pharmaceutical manufacturers, with...more
The McGuireWoods Women’s Health Newsletter delivers information on the latest legal and regulatory developments affecting the women’s health industry. The publication provides timely analysis of legislative changes,...more
In the wake of shootings in early March at hospitals in Atlanta and Milwaukee, the nation’s attention again turns to how to prevent workplace violence in health care settings....more
A bill introduced in the Virginia General Assembly aims to bring changes to nursing home licensure. House Bill No. 717 will require new operators to obtain a change of operator license before taking over daily operations...more
On February 19, 2026, the Mississippi Supreme Court ruled in Manhattan Nursing and Rehabilitation Center, LLC v. Hawkins that a wife who signed her husband’s nursing home admissions paperwork could not bind her husband to an...more
The U.S. Food and Drug Administration (FDA) published a draft guidance—the first of its kind—consolidating its expectations for how drug manufacturers should respond to Form 483 inspectional observations. The guidance applies...more
The rapidly expanding consumer biomarker testing market — a major pillar of the longevity ecosystem — has produced its first major lawsuit between competitors....more
On March 6, 2026, the Food and Drug Administration (“FDA” or “the Agency”) issued a draft guidance, “Responding to FDA Form 483 Observations at the Conclusion of a Drug CGMP Inspection.” The draft guidance articulates...more
On March 5, 2026, the U.S. Department of Health and Human Services (HHS) Office for Civil Rights (OCR) announced a settlement with MMG Fusion, LLC (MMG). MMG is a Maryland software company that was the subject of a complaint...more
Key Takeaways - The Missouri AG filed suit in St. Louis County Circuit Court against several PBMs and drug manufacturers, alleging they conspired to manipulate Missouri’s health care market and unlawfully drive up insulin...more
Our FDA: Drug & Device Team explores the Food and Drug Administration’s updated draft guidance that eases biosimilar development by allowing greater use of non-U.S.-licensed comparator products in clinical studies....more
Losing a loved one to the negligence of another person is devastating, but insult is added to injury when you begin to receive expensive bills for medical expenses, the funeral and the burial. This is only the beginning...more
No major healthcare legislation is currently scheduled for Senate floor consideration; healthcare policy activity is expected to remain concentrated at the committee level. Last week, the Senate Committee on Health,...more
In Fish & Richardson’s 2025 biologics and biosimilars review, we cover Food and Drug Administration (FDA) approvals, new biosimilar launches, Biologics Price Competition and Innovation Act (BPCIA) litigation and other...more
For years, the commercial compounding and telehealth industry blossomed, buoyed by exploding consumer interest in GLP-1s and other compounded drugs. But things are changing. We recently blogged more generally about the...more
New Jersey advanced practice nurses (“APNs”) and physician assistants (“PAs”) have until April 2, 2026, to secure collaborating or supervising physicians before pandemic-era practice waivers expire. Healthcare practices and...more
The Centers for Medicare and Medicaid Services (“CMS”) recently announced new healthcare fraud measures that include the imposition of a six-month moratorium on provider enrollments of new durable medical equipment,...more
On March 3, 2026, the U.S. District Court for the District of Columbia issued a significant decision for hospitals participating in the federal 340B Drug Pricing Program. In Albany Med Health System v. Health Resources and...more
The MHRA is seeking input on three proposed approaches to recognising the EU CE mark for medical devices in the UK....more
